HIV  1    The source for HIV information                  

Home

 News

Scientific

Updates

IRI

Feedback

HIV Clinical Trials  800-330-7284

CCR5 News

  news headlines

Alcohol use and HIV therapy

Antibody that Protects cells from HIV Virus discovered in Milan

New Study Claims Adherence and Suboptimal Drug Potency Cause of Virologic Failure

Documented Proof of HIV Reinfection

HIV Spread thru Oral Sex

HARS   (HIV Adiposity Redistribution Syndrome) 

 

The  Immunology  and  Retrovirology  Research   Institute   (IRI)  was founded in late 1993 as a non-profit, community-based,scientific research  institute by  scientists,  physicians  and  business   leaders.  The long-term mission of IRI is to become a leader in the scientific study of  the interactions that occur in HIV spectrum diseases, cancer and infective diseases.  There  is a  common  immunological thread between these  three  categories of human disease in which recognition and understanding of the basic immunologic response in  these  afflictions can lead  to the development of very specific  and target  immunologic  therapies for  their control and hopefully, their eventual cure.  nd hopefully, their eventual cure.  

                      

 

Find a Doctor in your area who specializes in HIV

Lipodystrophy Information Center

Espanol  Espanol       Italiano   Italiano      Deutsch  Deutsch       Français Francais       PortuguesBrazil

croce bianca     

 Legal Notice           

 

Send mail to webmaster@hiv1.com with questions or comments about this web site. Windows Server 2003 Home
Copyright © 2003  by Immunology and Retrovirology Research Institute, Inc.  All rights reserved.
Last modified: March 28, 2003